Skip to main content
. Author manuscript; available in PMC: 2018 Feb 14.
Published in final edited form as: Circulation. 2016 Dec 28;135(7):671–682. doi: 10.1161/CIRCULATIONAHA.116.021724

Table 7.

Logistic Regression Analysis with Generalized Estimating Equations of Brain Abnormalities using CBF as measured by PCMR indexed to BSA as a covariate

Endpoints Odds ratio (95% CI) P value
Non-acute Ischemic Changes T2
    Yes versus No 0.61 (0.43, 0.87) 0.0061
Periventricular Leukomalacia
    Yes versus No 0.88 (0.71, 1.10) 0.27
Focal Tissue Loss & Atrophy
    Yes versus No 0.50 (0.32, 0.77) 0.002
Ventriculomegaly
    Borderline versus No 1.00 (0.95, 1.04) 0.89
    Yes versus No 0.58 (0.32, 1.05) 0.0704
    Yes versus Borderline 0.57 (0.32, 1.00) 0.0496
SWI veins
    Borderline versus Normal 0.52 (0.34, 0.79) 0.0023
    Prominent versus Normal 0.74 (0.51, 1.09) 0.13
    Prominent versus Borderline 1.11 (0.73, 1.69) 0.61

CI, Confidence Interval.

The odds ratio is reported for 0.5 units (∼ 1 standard deviation) increase in CBF as measured by PCMR indexed to BSA.